Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl) phenoxy)-propanamido) benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism. J. Med Chem. 2017
Admin │ 2017-10-30 HIT 550 |
---|
이전글 | The Disubstituted adamantly derivative LW1564 inhibits the growth of HepG2 cance... |
---|---|
다음글 | The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer me... |